View All Key Stats
ISR Key Stats
| Income Statement | |
| Revenue (TTM) | 4.511M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.11 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -5.493M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 22.85% |
| Profit Margin (Quarterly) | -106.1% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 29.43M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 6.525 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.403 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -1.539M |
| Return on Equity (TTM) | -36.76% |
View All ISR News
ISR News
-
WireHeadlineTime (ET)
-
SA Breaking News08/04 08:51
-
PR Newswire08/04 08:00
-
PR Newswire08/01 09:05
-
MT Newswires07/07 16:16
-
PR Newswire07/07 08:00
-
MT Newswires07/06 09:34
-
PR Newswire07/06 08:00
-
MT Newswires06/20 09:23
-
SA Breaking News06/20 08:52
-
PR Newswire06/20 08:00
View All Events
ISR Events
| Date | Type | Description |
|---|---|---|
| 06/15/2017 | Misc | Special Meeting of Shareholders June 15, 2017 |
| 05/10/2017 | Earnings | IsoRay Inc Third Quarter Earnings Results in 2017 |
| 02/08/2017 | Earnings | IsoRay Inc Second Quarter Earnings Conference Call in 2017 |
| 12/14/2016 | Misc | IsoRay Inc Annual General Meeting in 2016 |
| 11/08/2016 10:00 EDT | Earnings | IsoRay Inc First Quarter Earnings Results in 2017 |
| 09/13/2016 10:00 EDT | Misc | IsoRay Inc Fourth Quarter Earnings Results in 2016 |
| 09/13/2016 | Earnings | IsoRay Inc Fourth Quarter Earnings Results in 2016 Release |
ISR Fundamentals
Income Statement View Statement
ISR Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ISR One Page Reports
- One Page Report Download
ISR Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 0.55 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.isoray.com
- Investor Relations URL: https://isoray.com/about/investors/
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Next Earnings Release: N/A
- Last Earnings Release: May. 10, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: IsoRay Inc offers solutions for the treatment and diagnosis of disease using medical isotopes. The Company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.
ISR Comparables
EditISR Excel Add-In Codes
- Name: =YCI("ISR","name")
- Description: =YCI("ISR","description")
- Sector: =YCI("ISR","sector")
- Industry: =YCI("ISR","industry")
- Est. Current Fiscal Year End: =YCI("ISR","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ISR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ISR Tweets Stocktwits
Advertisement
